Press Release: Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions in blood pressure in participants with chronic kidney disease – – In participants with chronic kidney disease and baseline albuminuria, lorundrostat significantly reduced urine albumin-to-creatinine ratio –
New findings uncover staggering triple-digit growth in state tax lien filings in New York, Georgia, Ohio, and more, signaling a tough new era of enforcement for taxpayers. New findings uncover staggering triple-digit growth in state tax lien filings in New York, Georgia, Ohio, and more, signaling a tough new era of enforcement for taxpayers.
METTAWA, Ill., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) will release its 2026 third quarter financial results on Thursday, October 29, 2026, before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website. The results will also…
VANCOUVER, BRITISH COLUMBIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) announces that it has acquired additional contiguous claims to its Junker Property in the Toodoggone Gold & Copper District of northern British Columbia.
Related Bing News Results Globe Newswire, World News and Updates | Calgary Sun Tue, 29 Sep 2026 16:13:00 GMT MONTRÉAL, Sept. 29, 2026 (GLOBE NEWSWIRE) — Top Aces Inc. (“Top Aces”) today announced that it has qualified as a supplier under three streams of the Government of Canada’s Defence Drone Initiative ...
